These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Progress in diffuse intrinsic pontine glioma: advocating for stereotactic biopsy in the standard of care. Williams JR; Young CC; Vitanza NA; McGrath M; Feroze AH; Browd SR; Hauptman JS Neurosurg Focus; 2020 Jan; 48(1):E4. PubMed ID: 31896081 [TBL] [Abstract][Full Text] [Related]
5. Epigenetic-Targeted Treatments for H3K27M-Mutant Midline Gliomas. Lu VM; Daniels DJ Adv Exp Med Biol; 2021; 1283():73-84. PubMed ID: 33155139 [TBL] [Abstract][Full Text] [Related]
6. H3K27-Altered Diffuse Midline Glioma of the Brainstem: From Molecular Mechanisms to Targeted Interventions. Nonnenbroich LF; Bouchal SM; Millesi E; Rechberger JS; Khatua S; Daniels DJ Cells; 2024 Jun; 13(13):. PubMed ID: 38994974 [TBL] [Abstract][Full Text] [Related]
8. Current perspectives on diffuse midline glioma and a different role for the immune microenvironment compared to glioblastoma. Pachocki CJ; Hol EM J Neuroinflammation; 2022 Nov; 19(1):276. PubMed ID: 36403059 [TBL] [Abstract][Full Text] [Related]
9. PRMT5 inhibition shows in vitro efficacy against H3K27M-altered diffuse midline glioma, but does not extend survival in vivo. Brown EJ; Balaguer-Lluna L; Cribbs AP; Philpott M; Campo L; Browne M; Wong JF; Oppermann U; Carcaboso ÁM; Bullock AN; Farnie G Sci Rep; 2024 Jan; 14(1):328. PubMed ID: 38172189 [TBL] [Abstract][Full Text] [Related]
10. Influence of socioeconomic status on clinical outcomes of diffuse midline glioma and diffuse intrinsic pontine glioma. Lee JH; Holste KG; Bah MG; Franson AT; Garton HJL; Maher CO; Muraszko KM J Neurosurg Pediatr; 2024 Jun; 33(6):507-515. PubMed ID: 38489807 [TBL] [Abstract][Full Text] [Related]
18. Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes. Castel D; Philippe C; Calmon R; Le Dret L; Truffaux N; Boddaert N; Pagès M; Taylor KR; Saulnier P; Lacroix L; Mackay A; Jones C; Sainte-Rose C; Blauwblomme T; Andreiuolo F; Puget S; Grill J; Varlet P; Debily MA Acta Neuropathol; 2015 Dec; 130(6):815-27. PubMed ID: 26399631 [TBL] [Abstract][Full Text] [Related]
19. The intrinsic and microenvironmental features of diffuse midline glioma: Implications for the development of effective immunotherapeutic treatment strategies. Persson ML; Douglas AM; Alvaro F; Faridi P; Larsen MR; Alonso MM; Vitanza NA; Dun MD Neuro Oncol; 2022 Sep; 24(9):1408-1422. PubMed ID: 35481923 [TBL] [Abstract][Full Text] [Related]
20. Adult diffuse intrinsic pontine glioma: clinical, radiological, pathological, molecular features, and treatments of 96 patients. Wang Y; Pan C; Xie M; Zuo P; Li X; Gu G; Li T; Jiang Z; Wu Z; Zhang J; Zhang L J Neurosurg; 2022 Dec; 137(6):1628-1638. PubMed ID: 35395636 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]